MedPath

The efficacy of Levothyroxin in euthyroid patient suffering from dysfunctional uterine bleeding

Phase 2
Conditions
Dysfunctional uterine bleeding.
Other specified abnormal uterine and vaginal bleeding
Registration Number
IRCT201303294686N2
Lead Sponsor
Arak University Medical of Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
120
Inclusion Criteria

age range 35 to 55 years and dysfunctional uterine bleeding.
Exclusion criteria: pregnancy; diabetes mellitus; hyperprolactinemia; coagulopathy; uterine fibroma; endocervical and endometrial polyp; atypical hyperplasia or adenocarcinoma; ovarian cyst; ovarian mass; hormontherapy; thyroid dysfunction and contraindication of oral contraceptivpills .

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Severity of uterine bleeding. Timepoint: Before intervention and at the end of intervention. Method of measurement: Clinical examination.
Secondary Outcome Measures
NameTimeMethod
Drug side effects. Timepoint: Before intervention and every 1 month. Method of measurement: Clinical examination.
© Copyright 2025. All Rights Reserved by MedPath